Voloridge Investment Management’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $9.03M | Sell |
173,441
-877,380
| -83% | -$45.7M | 0.03% | 577 |
|
|
2025
Q1 | $44.8M | Buy |
1,050,821
+454,139
| +76% | +$19.3M | 0.17% | 174 |
|
|
2024
Q4 | $18.2M | Sell |
596,682
-65,585
| -10% | -$2M | 0.06% | 376 |
|
|
2024
Q3 | $15.2M | Buy |
662,267
+120,314
| +22% | +$2.76M | 0.06% | 453 |
|
|
2024
Q2 | $15.7M | Sell |
541,953
-618,850
| -53% | -$17.9M | 0.06% | 452 |
|
|
2024
Q1 | $23.9M | Buy |
1,160,803
+267,256
| +30% | +$5.51M | 0.09% | 286 |
|
|
2023
Q4 | $24.2M | Sell |
893,547
-54,385
| -6% | -$1.47M | 0.1% | 276 |
|
|
2023
Q3 | $28.1M | Sell |
947,932
-30,277
| -3% | -$897K | 0.14% | 205 |
|
|
2023
Q2 | $35M | Sell |
978,209
-66,324
| -6% | -$2.37M | 0.17% | 174 |
|
|
2023
Q1 | $24.5M | Buy |
1,044,533
+583,615
| +127% | +$13.7M | 0.12% | 245 |
|
|
2022
Q4 | $12.5M | Buy |
460,918
+430,335
| +1,407% | +$11.7M | 0.07% | 372 |
|
|
2022
Q3 | $1.65M | Sell |
30,583
-63,956
| -68% | -$3.44M | 0.01% | 1038 |
|
|
2022
Q2 | $3.81M | Buy |
94,539
+90,051
| +2,006% | +$3.63M | 0.02% | 777 |
|
|
2022
Q1 | $297K | Buy |
+4,488
| New | +$297K | ﹤0.01% | 1273 |
|
|
2021
Q4 | – | Sell |
-42,725
| Closed | -$5.34M | – | 1664 |
|
|
2021
Q3 | $5.34M | Buy |
42,725
+38,597
| +935% | +$4.82M | 0.03% | 653 |
|
|
2021
Q2 | $513K | Buy |
+4,128
| New | +$513K | ﹤0.01% | 1435 |
|
|
2021
Q1 | – | Sell |
-33,269
| Closed | -$4.29M | – | 1492 |
|
|
2020
Q4 | $4.29M | Buy |
+33,269
| New | +$4.29M | 0.04% | 497 |
|
|
2019
Q4 | – | Sell |
-29,038
| Closed | -$1.85M | – | 1185 |
|
|
2019
Q3 | $1.85M | Buy |
+29,038
| New | +$1.85M | 0.03% | 471 |
|